Bk-Virus Nephropathy disease: Malacards - Research Articles, Drugs, Genes, Clinical Trials

BKN MCID: BKV001 MIFTS: 23	Bk-Virus Nephropathy (BKN) Categories: Nephrological diseases, Rare diseases
Tissues Related diseases Publications Drugs Expand all tables

Sources

Aliases & Classifications for Bk-Virus Nephropathy

MalaCards integrated aliases for Bk-Virus Nephropathy:

Name: Bk-Virus Nephropathy ⁵²

Bk Virus Nephropathy ⁵² ⁷¹

Nephropathy from Bk Virus ⁵²

Polyomavirus Nephropathy ⁵²

Bkn ⁵²

Classifications:

MalaCards categories:
Global: Rare diseases
Anatomical: Nephrological diseases

See all MalaCards categories (disease lists)

External Ids:

UMLS ⁷¹ C1697878

Sources

Summaries for Bk-Virus Nephropathy

MalaCards based summary : Bk-Virus Nephropathy, also known as bk virus nephropathy, is related to interstitial nephritis and polyomavirus-associated nephropathy. The drugs Tacrolimus and Basiliximab have been mentioned in the context of this disorder. Affiliated tissues include kidney, pancreas and testes.

Sources

Related Diseases for Bk-Virus Nephropathy

Diseases in the C1q Nephropathy family:

Bk-Virus Nephropathy

Diseases related to Bk-Virus Nephropathy via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 60)

#	Related Disease	Score
1	interstitial nephritis	10.4
2	polyomavirus-associated nephropathy	10.4
3	cystitis	10.4
4	end stage renal failure	10.4
5	hemorrhagic cystitis	10.3
6	glomerulonephritis	10.3
7	iga glomerulonephritis	10.3
8	myelodysplastic syndrome	10.2
9	lymphocytic leukemia	10.2
10	neutropenia	10.2
11	cytomegalovirus infection	10.2
12	leukemia, chronic lymphocytic	10.1
13	vesicoureteral reflux 1	10.1
14	hypertensive nephropathy	10.1
15	hepatitis c virus	10.1
16	epstein-barr virus hepatitis	10.1
17	exanthem	10.1
18	diffuse large b-cell lymphoma	10.1
19	cardiac arrest	10.1
20	lymphoproliferative syndrome	10.1
21	polycystic kidney disease	10.1
22	neuroretinitis	10.1
23	endocarditis	10.1
24	meningoencephalitis	10.1
25	alport syndrome	10.1
26	hydronephrosis	10.1
27	pyelonephritis	10.1
28	leukemia	10.1
29	pancytopenia	10.1
30	acute kidney tubular necrosis	10.1
31	dilated cardiomyopathy	10.1
32	uveitis	10.1
33	histoplasmosis	10.1
34	pulmonary tuberculosis	10.1
35	adenocarcinoma	10.1
36	retinitis	10.1
37	skin disease	10.1
38	bladder adenocarcinoma	10.1
39	rapidly progressive glomerulonephritis	10.1
40	proliferative glomerulonephritis	10.1
41	mesangial proliferative glomerulonephritis	10.1
42	kidney disease	10.1
43	progressive multifocal leukoencephalopathy	10.1
44	b-cell lymphoma	10.1
45	chickenpox	10.1
46	molluscum contagiosum	10.1
47	iridocyclitis	10.1
48	meningitis	10.1
49	post-transplant lymphoproliferative disease	10.1
50	rapidly involuting congenital hemangioma	10.1

Graphical network of the top 20 diseases related to Bk-Virus Nephropathy:

Sources

Symptoms & Phenotypes for Bk-Virus Nephropathy

Sources

Drugs & Therapeutics for Bk-Virus Nephropathy

Drugs for Bk-Virus Nephropathy (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 25)

Name

Status

Phase

Clinical Trials

Cas Number

PubChem Id

Tacrolimus

Approved, Investigational

Phase 4

104987-11-3

445643 439492 6473866

Synonyms:

(-)-FK 506

(3S,4R,5S,8R,9E,12S,14S,15R,16S,18R,19R,26aS)-5,19-dihydroxy-3-{(1E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl}-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(prop-2-en-1-yl)-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-3H-15,19-epoxypyrido[2,1-c][1,4]oxazacyclotricosine-1,7,20,21(4H,23H)-tetrone

104987-11-3

109581-93-3 (Hydrate)

15,19-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclotricosine-1,7,20,21(23H)-tetrone,

3S-[3R*[E(1S*,3S*,4S*)],4S*,5R*,8S*,9E,12R*,14R*,15S*,16R*,18S*,19S*,26aR*]]-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-5, 19-dihydroxy-3-[2-(4-hydroxy-3-methoxycyclohexyl)-1-methylethenyl]-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(2-propenyl)-15,19-epoxy-3H-pyrido[2,1-c] [1,4] oxaazacyclotricosine-1,7,20,21(4H,23H)-tetrone

8-DEETHYL-8-[BUT-3-ENYL]-ASCOMYCIN

AC-1182

AC1L1K7H

AC1L97GB

AC1L9IBU

Advagraf

AKOS005145901

Ambap104987-11-3

Ambap5429

Anhydrous tacrolimus

Anhydrous, tacrolimus

BCBcMAP01_000194

Bio-0921

Bio2_000470

Bio2_000950

BRD-K35452788-001-02-1

BSPBio_001279

BSPBio-001279

C01375

C44H69NO10

CCRIS 7124

CHEBI:100924

CHEBI:61049

CHEMBL1200738

CID11158639

CID11556866

CID439492

CID445643

CID5372

CID5472317

CID6426916

CID6436007

CID6473866

CID6536850

CID6610362

CID6912836

CID9832283

CID9853905

CID9918805

CID9940643

CID9963169

Cilag brand OF tacrolimus

CPD000466356

CPD-10016

D08556

DB00864

DivK1c_001040

FK 506

FK5

Fk-506

FK506

FK-506

FR 900506

FR900506

FR-900506

FT-0082660

Fujimycin

Fujisawa brand OF tacrolimus

Graceptor

HMS1362O21

HMS1792O21

HMS1990O21

HMS2051C18

HMS2093M19

HMS503O21

IDI1_001040

IDI1_002225

Janssen brand OF tacrolimus

K506

KBio1_001040

KBio2_000619

KBio2_003187

KBio2_005755

KBio3_001097

KBio3_001098

KBioGR_000619

KBioSS_000619

L 679934

L-679934

LCP-Tacro

LMPK04000003

LS-64247

MLS000759471

MLS001424054

Modigraf

MolPort-003-666-518

NCGC00163470-01

NCGC00163470-02

NCGC00163470-03

NCGC00163470-04

NCGC00179232-01

NChemBio.2007.16-comp1

nchembio.2007.23-comp2

NINDS_001040

NSC717865

Prograf

Prograf (TN)

Prograft

Protopic

Protopy

S5003_Selleck

SAM001246677

SMR000466356

Tacarolimus

tacrolimus

Tacrolimus

Tacrolimus (anhydrous)

Tacrolimus (INN)

Tacrolimus (Prograf?)

Tacrolimus anhydrous

tacrolimus hydrate

Tacrolimus, anhydrous

Tsukubaenolide

UNII-Y5L2157C4J

Basiliximab

Approved, Investigational

Phase 4

179045-86-4, 152923-56-3

Sirolimus

Approved, Investigational

Phase 4

53123-88-9

5284616 6436030 46835353

Synonyms:

(-)-rapamycin

(-)-Rapamycin

1fkb

1pbk

23,27-Epoxy-3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine

23,27-Epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine

23,27-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine-1,5,11,28,29

3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone

53123-88-9

A422989, NSC226080

AC1L1JH9

AC1L7MJ9

AC1L9ZMV

AC-722

Ambotz53123-88-9

Antibiotic AY 22989

AY 22989

AY22989

AY-22989

BIDD:PXR0165

Bio1_000293

Bio1_000782

Bio1_001271

Bio2_000375

Bio2_000855

BiomolKI2_000084

C07909

C51H79NO13

CBiol_002007

CCRIS 9024

CHEBI:100923

CHEBI:9168

CHEMBL413

CID10213190

CID10795871

CID11949238

CID11959112

CID313006

CID478951

CID5040

CID5284616

CID5358081

CID5374464

CID5460439

CID5497196

CID5924240

CID6436030

CID6610270

CID6610346

CID6711160

CID6713081

CID9833581

CID9854379

CID9854380

CID9962926

CID9962928

D00753

DB00877

DE-109

DivK1c_006936

FT-0082351

heptadecahydro-9,27-dihydroxy-3-[(1R)-2-[(1S,3R,4R)-4-hydroxy

HMS2089A21

HSDB 7284

KBio1_001880

KBio2_000410

KBio2_002978

KBio2_005546

KBio3_000779

KBio3_000780

KBioGR_000410

KBioSS_000410

LCP-Siro

LMPK06000003

LS-143290

MLS000028373

MolMap_000043

MolPort-003-959-433

MS-R001

NCGC00021305-05

nchembio.100-comp4

nchembio.2007.42-comp2

nchembio.79-comp1

nchembio762-comp1

nchembio883-comp3

NCI60_001851

NCIMech_000355

NSC 226080

NSC226080

Perceiva

QTL1_000069

R0395_SIAL

R0395_SIGMA

RAP

RAPA

Rapammune

Rapamune

Rapamune (TN)

rapamycin

Rapamycin

Rapamycin (TN)

Rapamycin C-7, analog 4

Rapamycin from Streptomyces hygroscopicus

Rapamycin Immunosuppressant Drug

RPM

S1039_Selleck

SIIA 9268A

SILA 9268A

SILA9268A

sirolimus

Sirolimus

Sirolimús

Sirolimus (RAPAMUNE)

Sirolimus (USAN/INN)

Sirolimus [USAN:BAN:INN]

Sirolimus, Rapamune,Rapamycin

Sirolimusum

SMP1_000255

SMR000058564

SpecPlus_000840

UNII-W36ZG6FT64

UNM-0000358684

Wy 090217

WY-090217

Everolimus

Approved

Phase 4

159351-69-6

6442177 70789204

Synonyms:

(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-Dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.0(sup 4,9))hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentaone

(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-Dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.04,9)hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentaone

(1R,9S,12S,15R,16E,23S,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.0(sup 4,9))hexatriacont

(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34as)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-9,27-dihydroxy-3-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-10,21-dimethoxy-6,8,12,14,20,26-hexamethy

(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-Hexadecahydro-9,27-dihydroxy-3-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-23,27-epoxy-3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone

(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-dihydroxy-3-{(2R)-1-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]propan-2-yl}-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-3H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone

001, RAD

07741_FLUKA

159351-69-6

40-O-(2-hydroxyethyl)-rapamycin

40-O-(2-Hydroxyethyl)-rapamycin

42-O-(2-Hydroxyethyl)rapamycin

Afinitor

Certican

CERTICAN(R)

CHEMBL1201755

D02714

DB01590

everolimus

Everolimus

évérolimus

Everolimus (JAN/USAN/INN)

Everolimus [USAN]

LS-143292

MolPort-003-847-342

MolPort-003-925-588

NCGC00167512-01

NVP-RAD-001

RAD 001

RAD, SDZ

RAD001

RAD-001

RAD001, SDZ-RAD, Certican, Zortress, Afinitor, Everolimus

RAD-001C

S1120_Selleck

SDZ RAD

SDZ-RAD

UNII-9HW64Q8G6G

Zortress

Miconazole

Approved, Investigational, Vet_approved

Phase 4

22916-47-8

4189

Synonyms:

(+-)-1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole

1-(2,4-dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl) imidazole

1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole

1-[2-(2,4-dichlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole

1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole

1-[2-(2,4-Dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]-1H-imidazole

1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]imidazole

1-[2-(2,4-dichlorophenyl)-2-{[(2,4-dichlorophenyl)methyl]oxy}ethyl]-1H-imidazole

1-[2,4-Dichloro- beta-([2,4-dichloro- benzyl]oxy)phenethyl]imidazole

1-{2-[(2,4-dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl}-1H-imidazole

22832-87-7 (NITRATE)

22916-47-8

75319-47-0

AB00053500

AC1L1HM1

Aflorix(nitrate)

AKOS001574474

Albistat(nitrate)

Andergin(nitrate)

BPBio1_000279

BRD-A82396632-001-03-0

BRD-A82396632-008-02-7

Brentan

BRN 0965511

BSPBio_000253

BSPBio_002033

CCRIS 7924

CHEBI:6923

CHEMBL91

CID4189

Conofite(nitrate)

CPD-4501

D00416

Dactarin

Daktarin IV

DB01110

DivK1c_000156

EINECS 245-324-5

Epi-Monistat(nitrate)

Esteve brand OF miconazole

Femizol-M

Florid(nitrate)

Gyno-Daktar(nitrate)

HMS1568M15

HMS2090B21

I14-14342

IDI1_000156

imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl) methoxy)ethyl)- (9CI)

Imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl)methoxy)ethyl)- (9CI)

Janssen cilag brand OF miconazole

Janssen-cilag brand OF miconazole

Johnston and johnston brand OF miconazole nitrate

KBio1_000156

KBio2_001445

KBio2_004013

KBio2_006581

KBio3_001533

KBioGR_000581

KBioSS_001445

Lotrimin AF(nitrate)

LS-78378

MCZ

Micantin (nitrate)

Miconasil nitrate

Miconasil Nitrate

Miconazol

Miconazol [INN-Spanish]

miconazole

Miconazole

Miconazole (JP15/USP/INN)

Miconazole [USAN:BAN:INN:JAN]

Miconazole 3

Miconazole 3 Combination Pack

Miconazole 7 Combination Pack

Miconazole esteve brand

Miconazole janssen-cilag brand

Miconazole nitrate

Miconazole nitrate salt

Miconazole-7

Miconazolo

Miconazolo [DCIT]

Miconazolum

Miconazolum [INN-Latin]

Micozole

Minostate

MJR 1762

MLS002222203

MolPort-002-557-553

Monazole 7

Monista (nitrate)

Monistat

Monistat (TN)

Monistat 1 Combination Pack

Monistat 3 Dual-Pak

Monistat 3 Vaginal Ovules

Monistat 5 Tampon

Monistat 7 Dual-Pak

Monistat 7 Vaginal Suppositories

Monistat Dual- PAK

Monistat IV

Monistat iv (TN)

Monistat-Derm

NCI60_001353

NCI60_001380

NINDS_000156

Nitrate, miconasil

Nitrate, miconazole

Novo-Miconazole Vaginal Ovules

NSC 170986

NSC169434

NSC170986

Oprea1_091955

Prestwick_335

Prestwick0_000067

Prestwick1_000067

Prestwick2_000067

Prestwick3_000067

R 18134

R-14,889

SMR001307249

SPBio_000976

SPBio_002174

Spectrum_000965

Spectrum2_001048

Spectrum3_000507

Spectrum4_000061

Spectrum5_001297

STK834405

STOCK1S-93556

UNII-7NNO0D7S5M

Vusion

Zimycan

Mycophenolic acid

Approved

Phase 4

24280-93-1

446541

Synonyms:

(e)-6-(4-Hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate

(e)-6-(4-Hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoic acid

Acid, mycophenolic

Acide mycophenolique

acido Micofenolico

Acido micofenolico

Acidum mycophenolicum

Melbex

micofenolico acido

Micofenolico acido

Mycophenoic acid

Mycophenolate

Mycophenolic acid

Mycophenolsaeure

Mycophenolsäure

Myfortic

Calcineurin Inhibitors

Phase 4

Dermatologic Agents

Phase 4

Antirheumatic Agents

Phase 4

Anti-Infective Agents

Phase 4

Antitubercular Agents

Phase 4

Antibiotics, Antitubercular

Phase 4

Anti-Bacterial Agents

Phase 4

Cyclosporins

Phase 4

Antifungal Agents

Phase 4

Immunosuppressive Agents

Phase 4

Immunologic Factors

Phase 4

rituximab

Approved

Phase 2

174722-31-7

10201696

Cidofovir

Approved

Phase 1, Phase 2

113852-37-2

60613

Synonyms:

({[(2S)-1-(4-amino-2-oxopyrimidin-1(2H)-yl)-3-hydroxypropan-2-yl]oxy}methyl)phosphonic acid

({[(S)-1-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3-hydroxypropan-2-yl]oxy}methyl)phosphonic acid

(2S)-3-Hydroxy-2-phosphonylmethoxypropyl-cytosine

(S)-(3-(4-amino-2-Oxopyrimidin-1(2H)-yl)-1-hydroxypropan-2-yloxy)methylphosphonate

(S)-(3-(4-amino-2-Oxopyrimidin-1(2H)-yl)-1-hydroxypropan-2-yloxy)methylphosphonic acid

(s)-[[2-(4-amino-2-oxo-1(2h)-pyrimidinyl)-1-(hydroxymethyl)ethoxy]methyl]phosphonic acid

(S)-1-(3-Hydroxy-2-phosphonomethoxypropyl)cytosine

(S)-1-[3-Hydroxy-2-(phosphonomethoxy)propyl]cytosine

(S)-1-[3-hydroxy-2-(phosphonylmethoxy)-propyl]cytosine

(S)-1-[3-Hydroxy-2-(phosphonylmethoxy)propyl]cytosine

(S)-2-(4-Amino-2-oxo-1(2H)-pyrimidinyl-1-(hydroxymethyl)ethoxy)methyl phosphonic acid

(S)-HPMPC

[(2S)-1-(4-amino-2-oxopyrimidin-1-yl)-3-hydroxypropan-2-yl]oxymethylphosphonic acid

[(S)-2-(4-amino-2-oxo-2H-Pyrimidin-1-yl)-1-hydroxymethyl-ethoxymethyl]-phosphonate

[(S)-2-(4-amino-2-oxo-2H-Pyrimidin-1-yl)-1-hydroxymethyl-ethoxymethyl]-phosphonic acid

[(S)-2-(4-Amino-2-oxo-2H-pyrimidin-1-yl)-1-hydroxymethyl-ethoxymethyl]-phosphonic acid

[[(S)-2-(4-amino-2-oxo-1(2H)-pyrimidinyl)-1-(hydroxymethyl)ethoxy]methyl]phosphonic acid

1-((3-Hydroxy-2-phosphonylmethoxy)propyl)cytosine

1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine

1-(3-Hydroxy-2-phosphonylmethoxypropyl)cytosine

1-(S)-[3-Hydroxy-2-(phosphonomethoxy)propyl]cytosine

1-[(S)-3-Hydroxy-2-(phosphonomethoxy)propyl]cytosine

1-[(S)-3-Hydroxy-2-(phosphonomethoxy)propyl]-cytosine dihydrate

113852-37-2

120362-37-0 (hydrochloride salt)

149394-66-1

AC-1666

AC1L1TLB

AC1Q6C68

AKOS005145721

C8H14N3O6P

CDV

CHEBI:3696

CHEMBL152

CID60613

Cidofovir

Cidofovir (anhydrous)

Cidofovir (Vistide)

Cidofovir anhydrous

Cidofovir sodium

Cidofovir, (+-)-isomer

Cidofovir, (R)-isomer

Cidofovir, sodium salt

Cidofovirum

DB00369

Forvade

GS 0504

GS 504

GS-0504

GS504

GS-504

HPMPC

HSDB 7115

LS-106432

MolPort-005-935-597

NSC742135

S1516_Selleck

UNII-768M1V522C

Vistide

Vistide, Cidofovir

Antibodies, Monoclonal

Phase 2

Antineoplastic Agents, Immunological

Phase 2

Antiviral Agents

Phase 1, Phase 2

Pancrelipase

Approved, Investigational

53608-75-6

Thymoglobulin

pancreatin

Interventional clinical trials:

(show all 12)

#	Name	Status	NCT ID	Phase	Drugs
1	Prospective, Multicenter, Randomized, Evaluating Two Induction Therapies With Simulect® Versus ATG® Fresenius Associated With Tacrolimus and Myfortic® in the Prevention of Treatment Failure, in Sensitized Renal Transplant	Completed	NCT02377193	Phase 4	Simulect;ATG Fresenius
2	Prospective Randomized Study to Characterize Risk Factors of Polyomavirus-related Transplant Nephropathy and the Impact of Three Immunosuppressive Regimens on Nephropathy Incidence	Completed	NCT00160966	Phase 4	Ciclosporin and Mycophenolate-mofetil;Tacrolimus and Mycophenolate-mofetil;Tacrolimus and Mycophenolate-mofetil with change from Mycophenolate-mofetil to Everolimus
3	Multicenter Randomized Two-arms Study Evaluating the BK Viral Clearance in Kidney Transplant Recipients With BK Viremia After Reduction of Immunosuppression Alone vs. Reduction of Immunosuppression and Replacement of Mycophenolate Mofetil by Everolimus	Recruiting	NCT03216967	Phase 4	everolimus
4	Impact of Rituximab Induction and Living Donation on Immunoregulation and Virus Control in Renal Transplantation - a Prospective Pilot Study	Completed	NCT01136395	Phase 2	Rituximab
5	Conversion From Tacrolimus to Envarsus in Rapid Metabolizers Post Kidney Transplant Protects Against BK Infection	Recruiting	NCT03762473	Phase 2	Study Group;Control Group
6	A Randomized, Placebo-Controlled, Dose-Escalation Study to Assess the Safety and Effect of Cidofovir in Renal Transplant Recipients With BK Virus Nephropathy	Terminated	NCT00138424	Phase 1, Phase 2	Cidofovir;Placebo
7	A Randomized, Double Blind, Placebo Controlled Study to Assess the Safety, Tolerability, and Efficacy of MAU868 for the Prevention of Allograft-threatening BK Virus Infection in Kidney Transplant Recipients	Withdrawn	NCT03456999	Phase 2
8	The Induction Agent Effect on BK Viremia in Renal and Pancreas Transplant Patients	Completed	NCT00610961
9	Evaluation of a Predictive Immunovirological Test Occurrence of BK Virus Nephropathy in Renal Transplant	Completed	NCT02049827
10	BK Viremia and BK Virus Nephropathy Post Kidney Transplant Comparison of New Practices With Traditional Approach: A Combined Retrospective Chart Review and Prospective Observational Study	Recruiting	NCT02758288
11	Validating Injury to Renal Transplant Using Urinary Signatures in Children	Recruiting	NCT03719339
12	Polyomavirus Aggregates, Haufen, in Voided Urine Samples as Diagnostic Biomarkers of Intra Renal BK-virus Disease: a Prospective Proof-of-concept Study	Enrolling by invitation	NCT01094691

Search NIH Clinical Center for Bk-Virus Nephropathy

Sources

Genetic Tests for Bk-Virus Nephropathy

Sources

Anatomical Context for Bk-Virus Nephropathy

MalaCards organs/tissues related to Bk-Virus Nephropathy:

⁴⁰

Kidney, Pancreas, Testes, Lung, Heart, B Cells, T Cells

Sources

Publications for Bk-Virus Nephropathy

Articles related to Bk-Virus Nephropathy:

(show top 50) (show all 254)

#	Title	Authors	PMID	Year
1	BK virus nephropathy without haemorrhagic cystitis following bone marrow transplantation. ⁶¹	Ghinai R...Moppett J	31621066	2020
2	Impact of Type 1 and Type 2 Diabetes Mellitus on Pancreas Transplant Outcomes. ⁶¹	Rohan V...Bratton C	30501589	2019
3	Prevalence and Risk Factors of BK Viremia and Clinical Impact of BK Virus Surveillance on Outcomes in Kidney Transplant Recipients: A Single-Center Cross-Sectional Study. ⁶¹	Ji J...Zhang X	30995893	2019
4	Effect of simultaneous presence of anti-blood group A/B and -HLA antibodies on clinical outcomes in kidney transplantation across positive crossmatch: a nationwide cohort study. ⁶¹	Kwon H...Korean Organ Transplantation Registry Study Group	31796812	2019
5	Outcomes of kidney retransplantation after graft loss as a result of BK virus nephropathy in the era of newer immunosuppressant agents. ⁶¹	Leeaphorn N...Cheungpasitporn W	31765056	2019
6	Identification of BK Virus Genotypes in Recipients of Renal Transplant in Vietnam. ⁶¹	Toan PQ...Su HX	31477425	2019
7	Simultaneous cytomegalovirus glomerulitis and BK virus nephropathy leading to kidney allograft loss. ⁶¹	Moktefi A...Grimbert P	31470994	2019
8	Urinary levels of CCL2 and CXCL10 chemokines as potential biomarkers of ongoing pathological processes in kidney allograft: an association with BK virus nephropathy. ⁶¹	Gniewkiewicz MS...Durlik M	31389404	2019
9	HLA-E Polymorphism Determines Susceptibility to BK Virus Nephropathy after Living-Donor Kidney Transplant. ⁶¹	Rohn H...Rebmann V	31394776	2019
10	Native kidney BK virus nephropathy, a systematic review. ⁶¹	Shah A...Hogan JJ	30907978	2019
11	The Pathophysiology and Impact of Inflammation in Nonscarred Renal Interstitium: The Banff i Lesion. ⁶¹	Nankivell BJ...Chapman JR	31369519	2019
12	Risk factors for death in kidney transplant patients: analysis from a large protocol biopsy registry. ⁶¹	Abeling T...Gwinner W	29860340	2019
13	Successful Treatment for BK Virus Nephropathy by Leflunomide in a Kidney Transplant Patient: A Case Report. ⁶¹	Wu MY...Wu MS	31084921	2019
14	Surgical Complications After Pediatric Renal Transplant. ⁶¹	Sozen H...Dalgic A	28128720	2019
15	Effects of Rituximab on Atherosclerotic Biomarkers in Kidney Transplant Recipients. ⁶¹	Aliyeva N...Turkmen A	31101184	2019
16	Do Antithymocyte Globulin-Free Acute Rejection Therapies Increase the Risk of Polyoma Nephropathy in Renal Transplant Recipients? ⁶¹	Gunay E...Toz H	31101182	2019
17	CD4+ T Cell Immune Response to VP1 and VP3 in BK Virus Infected Recipients of Renal Transplantation. ⁶¹	Fan Y...Shi B	30707648	2019
18	Monoclonal immunoglobulin G deposits on tubular basement membrane in renal allograft: is this significant for chronic allograft injury? ⁶¹	Sawada A...Nitta K	30124906	2019
19	Higher Incidence of BK Virus Nephropathy in Pediatric Kidney Allograft Recipients with Alport Syndrome. ⁶¹	Cho YH...Kang HG	30978953	2019
20	Bladder Carcinoma Associated with BK Virus in a Renal Allograft Recipient. ⁶¹	Gaur L...Rana DS	30983757	2019
21	BK virus nephropathy and multiorgan involvement in a child with heart transplantation . ⁶¹	Lee Y...Cho H	30526816	2019
22	Native kidney BK nephropathy: A case report. ⁶¹	Al Zein S...Kaur G	30847205	2019
23	The therapeutic effect of switching from tacrolimus to low-dose cyclosporine A in renal transplant recipients with BK virus nephropathy. ⁶¹	Chen XT...Huang G	30737303	2019
24	Screening for BK Viremia/Viruria and the Impact of Management of BK Virus Nephropathy in Renal Transplant Recipients. ⁶¹	Zakaria ZE...Al-Otaibi T	30777529	2019
25	A urinary Common Rejection Module (uCRM) score for non-invasive kidney transplant monitoring. ⁶¹	Sigdel TK...Sarwal MM	31365568	2019
26	Living-Donor Kidney Transplant With Preformed Donor-Specific Antibodies. ⁶¹	Itabashi Y...Shishido S	30777522	2019
27	Clinical Significance of Renal Allograft Protocol Biopsies: A Single Tertiary Center Experience in Malaysia. ⁶¹	Fu MS...Ng KP	31186948	2019
28	BK Virus Nephropathy. ⁶¹	Sawinski D...Trofe-Clark J	30242026	2018
29	BK Virus nephropathy in living donor renal allograft recipients: An observational study from a large transplant center in India. ⁶¹	Gupta P...Rana DS	30588968	2018
30	Abnormalities in Protocol Graft Kidney Biopsy 6 Months Posttransplantation in a Tertiary Care Center Hospital of Nepal. ⁶¹	Shrestha M...Kafle MP	30316361	2018
31	BK virus-induced renal allograft nephropathy. ⁶¹	Krejci K...Zadrazil J	29765170	2018
32	Prevalence of BK virus among renal transplant recipients in a tertiary care hospital in Sri Lanka ⁶¹	Premathilake MI...Lanerolle RD	30415516	2018
33	Clinical characteristics and outcomes of late-onset BK virus nephropathy in kidney and kidney-pancreas transplant recipients. ⁶¹	Imlay H...Limaye AP	29809315	2018
34	Fluoroquinolones and BK Virus Nephropathy: A Myth or a Reality. ⁶¹	Khalil MAM...Khan TFT	30158742	2018
35	The utility of surveillance biopsies in pediatric kidney transplantation. ⁶¹	Dharnidharka VR...Hmiel SP	29260318	2018
36	Urine biomarkers informative of human kidney allograft rejection and tolerance. ⁶¹	Nissaisorakarn V...Suthanthiran M	29366869	2018
37	Aryl hydrocarbon receptor expression by macrophages and lymphocytes within infiltrates in BK polyomavirus associated nephropathy. ⁶¹	Bouatou Y...Florquin S	29305091	2018
38	Identification of potential key protein interaction networks of BK virus nephropathy in patients receiving kidney transplantation. ⁶¹	Jia L...Zhang H	29567951	2018
39	T cell-mediated rejection is a major determinant of inflammation in scarred areas in kidney allografts. ⁶¹	Lefaucheur C...Loupy A	29086461	2018
40	Collapsing Glomerulopathy- A Troublemaker for the Renal Allograft: Lessons Learnt. ⁶¹	Kanodia KV...Trivedi HL	28904428	2017
41	BK Virus Nephropathy: Histological Evolution by Sequential Pathology. ⁶¹	Nankivell BJ...Chapman JR	28371308	2017
42	BK Virus Nephropathy Revisited. ⁶¹	Mengel M	28510315	2017
43	BK viremia surveillance and outcomes in simultaneous pancreas-kidney transplant recipients. ⁶¹	Westphal SG...Miles CD	28509373	2017
44	Biopsy-Proven BK Virus-Associated Nephropathy: Clinico-Pathologic Correlations. ⁶¹	Jahdali S...Al Sayyari A	28137206	2017
45	Outcomes of Hepatitis C-Positive Kidney Transplant Recipients Compared With Hepatitis C-Negative Recipients in Today's Era of Immunosuppression: A UNOS Database Analysis With Long-Term Follow-Up. ⁶¹	Khalil A...Sharfuddin A	27310008	2017
46	De Novo Collapsing Glomerulopathy in Renal Allograft in Association with BK Virus Nephropathy in a Child and Stabilization of Renal Function by Elimination of Viremia. ⁶¹	Gera DN...Trivedi HL	28553047	2017
47	Tacrolimus Blood Level Fluctuation Predisposes to Coexisting BK Virus Nephropathy and Acute Allograft Rejection. ⁶¹	Shen CL...Yang CY	28512328	2017
48	Clearance of BK Virus Nephropathy by Combination Antiviral Therapy With Intravenous Immunoglobulin. ⁶¹	Kable K...Nankivell BJ	28405598	2017
49	Combination of Leflunomide and Everolimus for treatment of BK virus nephropathy. ⁶¹	Jaw J...Goodman D	28247521	2017
50	Successful Cost-Effective Prevention of Cytomegalovirus Disease in Kidney Transplant Recipients Using Low-Dose Valganciclovir. ⁶¹	Gheith O...Nampoory N	28260458	2017

Sources

Genes for Bk-Virus Nephropathy

Sources

Variations for Bk-Virus Nephropathy

Sources

Expression for Bk-Virus Nephropathy

Search GEO for disease gene expression data for Bk-Virus Nephropathy.

Sources

Pathways for Bk-Virus Nephropathy

Sources

GO Terms for Bk-Virus Nephropathy

Sources

Sources for Bk-Virus Nephropathy

¹ BioSystems

² BitterDB

³ CDC

⁴ Cell Signaling Technology

⁵ ClinicalTrials

⁶ ClinVar

⁷ CNVD

⁸ Cochrane Library

⁹ Cosmic

¹⁰ dbSNP

¹¹ DGIdb

¹² Disease Ontology

¹³ diseasecard

¹⁴ DiseaseEnhancer

¹⁵ DISEASES

¹⁶ DrugBank

¹⁷ EFO

¹⁸ ExPASy

¹⁹ FMA

²⁰ GeneAnalytics

²¹ GeneCards

²² GeneGo (Thomson Reuters)

²³ GeneHancer via GeneCards

²⁴ GeneReviews

²⁵ Genetics Home Reference

²⁶ GenomeRNAi

²⁷ GEO DataSets

²⁸ GO

²⁹ GTR

³⁰ HMDB

³¹ HPO

³² ICD10

³³ ICD10 via Orphanet

³⁴ ICD9CM

³⁵ IUPHAR

³⁶ KEGG

³⁷ LifeMap

³⁸ LncRNADisease

³⁹ LOVD

⁴⁰ MalaCards

⁴¹ MedGen

⁴² MedlinePlus

⁴³ MeSH

⁴⁴ MESH via Orphanet

⁴⁵ MGI

⁴⁶ miR2Disease

⁴⁷ NCBI Bookshelf

⁴⁸ NCI

⁴⁹ NCIt

⁵⁰ NDF-RT

⁵¹ NIH Clinical Center

⁵² NIH Rare Diseases

⁵³ NINDS

⁵⁴ Novoseek

⁵⁵ Novus Biologicals

⁵⁶ OMIM

⁵⁷ OMIM via Orphanet

⁵⁸ Orphanet

⁵⁹ PathCards

⁶⁰ PharmGKB

⁶¹ PubMed

⁶² PubMed Health

⁶³ QIAGEN

⁶⁴ R&D Systems

⁶⁵ Reactome

⁶⁶ Sino Biological

⁶⁷ SNOMED-CT

⁶⁸ SNOMED-CT via HPO

⁶⁹ TGDB

⁷⁰ Tocris

⁷¹ UMLS

⁷² UMLS via Orphanet

⁷³ UniProtKB/Swiss-Prot

⁷⁴ Wikipedia

Bk-Virus Nephropathy (BKN)

Aliases & Classifications for Bk-Virus Nephropathy

MalaCards integrated aliases for Bk-Virus Nephropathy:

Classifications:

External Ids:

Summaries for Bk-Virus Nephropathy

Related Diseases for Bk-Virus Nephropathy

Diseases in the C1q Nephropathy family:

Diseases related to Bk-Virus Nephropathy via text searches within MalaCards or GeneCards Suite gene sharing:

Graphical network of the top 20 diseases related to Bk-Virus Nephropathy:

Symptoms & Phenotypes for Bk-Virus Nephropathy

Drugs & Therapeutics for Bk-Virus Nephropathy

Drugs for Bk-Virus Nephropathy (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

Interventional clinical trials:

Genetic Tests for Bk-Virus Nephropathy

Anatomical Context for Bk-Virus Nephropathy

MalaCards organs/tissues related to Bk-Virus Nephropathy:

Publications for Bk-Virus Nephropathy

Articles related to Bk-Virus Nephropathy:

Genes for Bk-Virus Nephropathy

Variations for Bk-Virus Nephropathy

Expression for Bk-Virus Nephropathy

Pathways for Bk-Virus Nephropathy

GO Terms for Bk-Virus Nephropathy

Sources for Bk-Virus Nephropathy